FDA approves Revolution Medicines pancreatic cancer drug Rasonque
Go back to FDA approves Revolution Medicines pancreatic cancer drug Rasonque| (NASDAQ: RVMD) | Delayed: 192.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $192.76 | 52 Week High | $ | |||
| Open | $192.76 | 52 Week Low | $ | |||
| Day High | $192.76 | P/E | N/A | |||
| Day Low | $192.76 | EPS | $ | |||
| Volume | 631 | |||||

